Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Visceral Leishmaniosis”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Not applicableStudy completedNCT05449717
What this trial is testing

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Who this might be right for
LeishmaniasisLeishmaniasis, VisceralPost-kala-azar Dermal Leishmaniasis
Epicentre 52
Post-approval studies (Phase 4)Ended earlyNCT01310738
What this trial is testing

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil

Who this might be right for
Visceral Leishmaniasis
University of Brasilia 378
Large-scale testing (Phase 3)Study completedNCT00696969
What this trial is testing

Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 634
Post-approval studies (Phase 4)Study completedNCT03311607
What this trial is testing

Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
Medecins Sans Frontieres, Netherlands 280
Early research (Phase 1)Study completedNCT02071758
What this trial is testing

Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers

Who this might be right for
Visceral Leishmaniasis
Access to Advanced Health Institute (AAHI) 39
Not applicableUnknownNCT01138956
What this trial is testing

Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine

Who this might be right for
Visceral LeishmaniasisImmune ResponseTreatment
Hospital Universitário Professor Edgard Santos 40
Large-scale testing (Phase 3)Study completedNCT01122771
What this trial is testing

Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 602
Not applicableStudy completedNCT03269006
What this trial is testing

Improved Case Detection and Vector Control for Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 202
Large-scale testing (Phase 3)Study completedNCT00255567
What this trial is testing

Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 1,142
Large-scale testing (Phase 3)Study completedNCT00629031
What this trial is testing

An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 329
Testing effectiveness (Phase 2)Ended earlyNCT00378495
What this trial is testing

Miltefosine for Brazilian Visceral Leishmaniasis

Who this might be right for
Kala Azar
AB Foundation 80
Not applicableStudy completedNCT00342823
What this trial is testing

Immunogenetics of Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
National Human Genome Research Institute (NHGRI) 7,000
Not applicableUnknownNCT05386875
What this trial is testing

Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in Kenya

Who this might be right for
Visceral Leishmaniasis
Foundation for Innovative New Diagnostics, Switzerland 625
Large-scale testing (Phase 3)Study completedNCT02193022
What this trial is testing

Miltefosine for Children With PKDL

Who this might be right for
Post Kala Azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 80
Post-approval studies (Phase 4)UnknownNCT01566552
What this trial is testing

Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 1,300
Large-scale testing (Phase 3)Study completedNCT02011958
What this trial is testing

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 59
Not applicableLooking for participantsNCT00344188
What this trial is testing

Diagnosis and Treatment of Leishmania Infections

Who this might be right for
LeishmaniasisSkin Diseases, ParasiticEuglenozoa Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 289
Testing effectiveness (Phase 2)WithdrawnNCT01437020
What this trial is testing

SCH708980 With and Without AmBisome for Visceral Leishmaniasis

Who this might be right for
LeishmaniasisEffects of Immunotherapy
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00310505
What this trial is testing

Amphotericin B Treatment in Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 1,500
Testing effectiveness (Phase 2)Ended earlyNCT01980199
What this trial is testing

Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 14
Load More Results